» Articles » PMID: 32979059

Radiomic Analysis of Magnetic Resonance Fingerprinting in Adult Brain Tumors

Overview
Date 2020 Sep 26
PMID 32979059
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This is a radiomics study investigating the ability of texture analysis of MRF maps to improve differentiation between intra-axial adult brain tumors and to predict survival in the glioblastoma cohort.

Methods: Magnetic resonance fingerprinting (MRF) acquisition was performed on 31 patients across 3 groups: 17 glioblastomas, 6 low-grade gliomas, and 8 metastases. Using regions of interest for the solid tumor and peritumoral white matter on T1 and T2 maps, second-order texture features were calculated from gray-level co-occurrence matrices and gray-level run length matrices. Selected features were compared across the three tumor groups using Wilcoxon rank-sum test. Receiver operating characteristic curve analysis was performed for each feature. Kaplan-Meier method was used for survival analysis with log rank tests.

Results: Low-grade gliomas and glioblastomas had significantly higher run percentage, run entropy, and information measure of correlation 1 on T1 than metastases (p < 0.017). The best separation of all three tumor types was seen utilizing inverse difference normalized and homogeneity values for peritumoral white matter in both T1 and T2 maps (p < 0.017). In solid tumor T2 maps, lower values in entropy and higher values of maximum probability and high-gray run emphasis were associated with longer survival in glioblastoma patients (p < 0.05). Several texture features were associated with longer survival in glioblastoma patients on peritumoral white matter T1 maps (p < 0.05).

Conclusion: Texture analysis of MRF-derived maps can improve our ability to differentiate common adult brain tumors by characterizing tumor heterogeneity, and may have a role in predicting outcomes in patients with glioblastoma.

Citing Articles

Textural analysis and artificial intelligence as decision support tools in the diagnosis of multiple sclerosis - a systematic review.

Orzan F, Iancu S, Diosan L, Balint Z Front Neurosci. 2025; 18:1457420.

PMID: 39906910 PMC: 11790655. DOI: 10.3389/fnins.2024.1457420.


Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.

Song D, Fan G, Chang M Cancers (Basel). 2025; 17(1.

PMID: 39796702 PMC: 11719598. DOI: 10.3390/cancers17010074.


Time-resolved MR fingerprinting for T* signal extraction: MR fingerprinting meets echo planar time-resolved imaging.

Cui D, Liu X, Larson P, Xu D Magn Reson Med. 2024; 93(4):1751-1760.

PMID: 39567357 PMC: 11842023. DOI: 10.1002/mrm.30381.


Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies.

Nguyen T, Greene L, Mnatsakanyan H, Badr C Biomedicines. 2024; 12(6).

PMID: 38927583 PMC: 11202201. DOI: 10.3390/biomedicines12061376.


Emerging Trends in Magnetic Resonance Fingerprinting for Quantitative Biomedical Imaging Applications: A Review.

Monga A, Singh D, De Moura H, Zhang X, Zibetti M, Regatte R Bioengineering (Basel). 2024; 11(3).

PMID: 38534511 PMC: 10968015. DOI: 10.3390/bioengineering11030236.


References
1.
Sottoriva A, Spiteri I, Piccirillo S, Touloumis A, Collins V, Marioni J . Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013; 110(10):4009-14. PMC: 3593922. DOI: 10.1073/pnas.1219747110. View

2.
Parker N, Khong P, Parkinson J, Howell V, Wheeler H . Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol. 2015; 5:55. PMC: 4347445. DOI: 10.3389/fonc.2015.00055. View

3.
Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

4.
Colman H, Zhang L, Sulman E, McDonald J, Shooshtari N, Rivera A . A multigene predictor of outcome in glioblastoma. Neuro Oncol. 2010; 12(1):49-57. PMC: 2940562. DOI: 10.1093/neuonc/nop007. View

5.
Aibaidula A, Chan A, Shi Z, Li Y, Zhang R, Yang R . Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol. 2017; 19(10):1327-1337. PMC: 5596181. DOI: 10.1093/neuonc/nox078. View